PATENT CLAIM ANALYSIS

Application Number: 16012417
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "489000"]

Abstract:
The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.

Claim (Index 12):
The method according to  claim 10 , wherein the cancer is chronic lymphocytic leukemia.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 94.0
- Lexical Diversity: 1.46875
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13969724', '11330868', '13654898', '13719379', '13719409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8142786248414516
- 35 USC 102 Novelty (BERT): 0.5468432985977311
- Combined Prediction Score: 0.7875350922170796
- Mean Citation Score: 415.457802
- Max Citation Score: 440.6927
- Similarity Product: 260.4727989286304

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test